Antiplatelet Therapy

TACSI Trial Finds No Benefit of Dual Antiplatelet Therapy After CABG, Higher Bleeding Risk

The 2,201-patient study challenges guideline recommendations for routine ticagrelor plus aspirin after bypass surgery.